Antioxidant activity of xanthone derivatives

2016
journal article
article
dc.abstract.enCertain xanthone derivatives, such as these present in mangosteen fruits, show strong antioxidant activity. On the other hand, evidences accumulated that oxidative stress is involved in epileptogenesis. Therefore, the aim of the present study was to estimate total antioxidant capacity (expressed as a ferric reducing antioxidant power - FRAP) and evaluate ability to scavenge free radicals (DPPH methods) by xanthone derivatives showing antiepileptic activity. Selected 2-(aminomethyl)-9H-xanthen-9-one derivatives shared structural features, such as chlorine substituent in xanthone ring and different chiral (or not) alkanol groups at the nitrogen atom. The results of antioxidant activities among racemates revealed the highest activity for compound (R/S)-3 (31.7% in diphenyl-2-picrylhydrazyl (DPPH) radical scavenging and (0.184 ± 0.003 mM Fe2+/L) in FRAP assay. Among tested pair of enantiomers we observed that (R)-1 and (R)-2 showed higher reduction capacity ((R)ñ1: 0.096 ± 0.007 mM Fe2+/L; (R)-2: 0.048 ± 0.005 mM Fe2+/L, respectively) and strongerDPPH scavenging activity ((R)-1: 31 ± 3.0%; (R)-2: 29 ± 2.5%, respectively) comparing to their (S)-enantiomers and racemates.pl
dc.affiliationWydział Farmaceutyczny : Zakład Chemii Bioorganicznejpl
dc.cm.date2020-01-07
dc.cm.id79527
dc.contributor.authorFrancik, Renata - 129384 pl
dc.contributor.authorSzkaradek, Natalia - 162261 pl
dc.contributor.authorŻelaszczyk, Dorota - 200888 pl
dc.contributor.authorMarona, Henryk - 200513 pl
dc.date.accession2016-12-06pl
dc.date.accessioned2020-01-17T09:10:33Z
dc.date.available2020-01-17T09:10:33Z
dc.date.issued2016pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr. s. 1509pl
dc.description.number6pl
dc.description.physical1505-1509pl
dc.description.points15pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume73pl
dc.identifier.eissn2353-5288pl
dc.identifier.issn0001-6837pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/138939
dc.identifier.weblinkhttps://www.ptfarm.pl/download/?file=File%2FActa_Poloniae%2F2016%2F6%2F1505.pdfpl
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.enxanthone derivativespl
dc.subject.enoxidative stresspl
dc.subject.enDPPH test, FRAPpl
dc.subtypeArticlepl
dc.titleAntioxidant activity of xanthone derivativespl
dc.title.journalActa Poloniae Pharmaceutica. Drug Researchpl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
Certain xanthone derivatives, such as these present in mangosteen fruits, show strong antioxidant activity. On the other hand, evidences accumulated that oxidative stress is involved in epileptogenesis. Therefore, the aim of the present study was to estimate total antioxidant capacity (expressed as a ferric reducing antioxidant power - FRAP) and evaluate ability to scavenge free radicals (DPPH methods) by xanthone derivatives showing antiepileptic activity. Selected 2-(aminomethyl)-9H-xanthen-9-one derivatives shared structural features, such as chlorine substituent in xanthone ring and different chiral (or not) alkanol groups at the nitrogen atom. The results of antioxidant activities among racemates revealed the highest activity for compound (R/S)-3 (31.7% in diphenyl-2-picrylhydrazyl (DPPH) radical scavenging and (0.184 ± 0.003 mM Fe2+/L) in FRAP assay. Among tested pair of enantiomers we observed that (R)-1 and (R)-2 showed higher reduction capacity ((R)ñ1: 0.096 ± 0.007 mM Fe2+/L; (R)-2: 0.048 ± 0.005 mM Fe2+/L, respectively) and strongerDPPH scavenging activity ((R)-1: 31 ± 3.0%; (R)-2: 29 ± 2.5%, respectively) comparing to their (S)-enantiomers and racemates.
dc.affiliationpl
Wydział Farmaceutyczny : Zakład Chemii Bioorganicznej
dc.cm.date
2020-01-07
dc.cm.id
79527
dc.contributor.authorpl
Francik, Renata - 129384
dc.contributor.authorpl
Szkaradek, Natalia - 162261
dc.contributor.authorpl
Żelaszczyk, Dorota - 200888
dc.contributor.authorpl
Marona, Henryk - 200513
dc.date.accessionpl
2016-12-06
dc.date.accessioned
2020-01-17T09:10:33Z
dc.date.available
2020-01-17T09:10:33Z
dc.date.issuedpl
2016
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr. s. 1509
dc.description.numberpl
6
dc.description.physicalpl
1505-1509
dc.description.pointspl
15
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
73
dc.identifier.eissnpl
2353-5288
dc.identifier.issnpl
0001-6837
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/138939
dc.identifier.weblinkpl
https://www.ptfarm.pl/download/?file=File%2FActa_Poloniae%2F2016%2F6%2F1505.pdf
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC
dc.rights.uri*
http://creativecommons.org/licenses/by-nc/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
xanthone derivatives
dc.subject.enpl
oxidative stress
dc.subject.enpl
DPPH test, FRAP
dc.subtypepl
Article
dc.titlepl
Antioxidant activity of xanthone derivatives
dc.title.journalpl
Acta Poloniae Pharmaceutica. Drug Research
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
67
Views per month
Views per city
Cologne
7
Los Angeles
7
Serdang
4
Bangkok
2
Des Moines
2
Dublin
2
Gangseo-gu
2
Ho Chi Minh City
2
Jakarta
2
Santiago
2
Downloads
francik_et-al_antioxidant_activity_of_xanthone_derivatives_2016.pdf
230
francik_et-al_antioxidant_activity_of_xanthone_derivatives_2016.odt
14